Inventor
Peter Van Vlasselaer
Inventor
Portola Valley, CA, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
A61KPreparations for medical, dental or toiletry purposes12%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
C07KPeptides12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
C12YEnzymes8%
A01NPreservation of bodies of humans or animals or plants or parts thereof6%
B01LChemical or physical laboratory apparatus for general use6%
A61MDevices for introducing media into, or onto, the body4%
C12NMicroorganisms or enzymes4%
PatentTitleYear
10,494,443LOX and LOXL2 inhibitors and uses thereof201910,457,745Anti-complement C1s antibodies201910,450,382Anti-complement C1s antibodies201910,209,261Method for assessing protein identity and stability20199,823,255'Method for assessing protein identity and stability'20179,562,106'Anti-complement C1s antibodies and methods of inhibiting complement C1s activity'20179,562,092'Methods of inhibiting complement C4 activation with anti-complement C1s antibodies'20179,512,233'Anti-complement C1s antibodies and methods of inhibiting complement C1s activity'20169,206,259'Methods of inhibiting complement C4 activation with anti-complement C1S antibodies'20159,176,139'LOX and LOXL2 inhibitors and uses thereof'20159,074,003'Methods of inhibiting activation of complement component C4 with anti-C1s antibodies'20159,074,004'Methods of inhibiting activation of complement component C4 with anti-C1s antibodies'20158,945,562'Anti-complement C1s antibodies'20158,877,197'Anti-complement C1s'20148,679,485'Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis'20148,658,167'Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis'20148,461,303'LOX and LOXL2 inhibitors and uses thereof'20136,197,579'Cell washing device and method'20016,015,843'Process for making silanized colloidal silica'20005,840,502'Methods for enriching specific cell-types by density gradient centrifugation'19985,789,148'Cell separation composition'19985,648,223'Methods for enriching breast tumor cells'19975,646,004'Methods for enriching fetal cells from maternal body fluids'19975,577,513'Centrifugation syringe, system and method'19965,474,687'Methods for enriching CD34.sup.+ human hematopoietic progenitor cells'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–1998Patents assigned to ACTIVATED CELL THERAPY INC (5)· patent assignee history
1995–2001Based in Sunnyvale, CA, US· patent location history
1998–2001Patents assigned to DENDREON CORP (3)· patent assignee history
2013–2019Patents assigned to GILEAD BIOLOGICS INC (5)· patent assignee history
2013–2019Based in Portola Valley, CA, US· patent location history
2014–2017Patents assigned to TRUE NORTH THERAPEUTICS INC (8)· patent assignee history
2017–2019Patents assigned to ARMO BIOSCIENCES INC (2)· patent assignee history
2017–2019Based in Woodside, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TRUE NORTH THERAPEUTICS INC | 8 | 2014–2017 |
| ACTIVATED CELL THERAPY INC | 5 | 1995–1998 |
| GILEAD BIOLOGICS INC | 5 | 2013–2019 |
| DENDREON CORP | 3 | 1998–2001 |
| ARMO BIOSCIENCES INC | 2 | 2017–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Portola Valley, California, US | 15 | 2013–2019 |
| Sunnyvale, California, US | 8 | 1995–2001 |
| Woodside, California, US | 2 | 2017–2019 |